Posts

Amgen’s Imdelltra lands major new lung cancer victory

on

Akeso broadens ivonescimab ambitions after biliary tract cancer win

on

AZ stays on track for $80B revenue goal as cancer meds, rare disease sales help offset Ultomiris miss

on

AstraZeneca's triplet combo (Imfinzi/Imjudo/lenvatinib) plus TACE helps a subset of liver cancer patients avoid progression

on

AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi

on

Imfinzi Gains FDA Approval for Early Gastric and GEJ Cancers; BiomX Nebulizer Faces FDA Scrutiny

on

AstraZeneca Beats Q2 Estimates on Strong Cancer Drug Sales

on

AstraZeneca opens the door to Imfinzi expansion with trial win in high-risk bladder cancer patients

on